Efficacy and Safety of CKDB-501A in Subjects With Moderate-to-severe Glabellar Lines in Phase 3 Trial
Clinical trial NCT05804656 · COMPLETED
Trial details
- NCT number
- NCT05804656
- Sponsor
- CKD Bio Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-13
- Primary completion
- 2023-08-29
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.